Cargando…
Biosimilars Adoption: Recognizing and Removing the RoadBlocks
Almost two decades since biosimilars arrived, we still await their broader adoption, as anticipated. The roadblocks to this adoption include the high amortized cost of goods due to regulatory burden, hurdles created by the distribution system, perception of safety and efficacy, and lack of focus by...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106314/ https://www.ncbi.nlm.nih.gov/pubmed/37077364 http://dx.doi.org/10.2147/CEOR.S404175 |